MCAZ PVCT GL02 Rev 2 May 2024 PHARMACOVIGILANCE GUIDELINE FOR PHARMACEUTICAL INDUSTRY

MCAZ-PVCT-GL03-Rev-1_May-2024 Guideline for Pharmacovigilance of COVID 19 Vaccine AEFI Safety Surveillance

MCAZ-PVCT- GL01 Rev 1 May 2024 Guidelines For Conducting Good Clinical Practice (GCP) Inspections in Zimbabwe

MCAZ PVCT GL06 Rev 2_November 2023 Pharmacy Guidelines for Investigational Medical Products

Circular 16 of 2021 – Use of Ivermectin human oral formulations for prevention and or treatment of COVID 19

Zimbabwe National Pharmacovigilance Policy Handbook

Adverse Events Following Immunization Surveillance Guidelines 3rd Edition